Vishakha Sabharwal, MBBS

Clinical Associate Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Vishakha Sabharwal, MD is a Clinical Associate Professor of Pediatrics at Boston University Medical Center and a Pediatrics Infectious Disease Attending. She also helps run the Pediatrics Infectious Diseases Fellowship program as an Associate Program Director. Besides inpatient consults, she sees patients in the International and Refugee Clinic and TB clinic. Her research includes perinatal infections especially viral infections like HCV and SARS–Cov2 transmission from mother to infant. She is a co-investigator on an NIH R01 grant that studies how to prevent and treat Ear Infections and Ear Drainage and the prevention of biofilms after ear tube placement. She has extensive experience as a clinical researcher and has participated in vaccine and drug trials and has received funding from the Shereta Seelig Charitable Foundation Trust and the National Institutes of Health. In addition to lecturing regularly, Dr. Sabharwal has mentored students and trainees who have gone on to become senior research assistants, faculty, fellows, and residents. She is a member of the Infectious Diseases Society of America, the Pediatrics Infectious Disease Society, the Medical Society of the State of Massachusetts, and the Massachusetts Infectious Disease Society.

Publications

  • Published 5/5/2026

    Fisher SA, Sandoval GJ, Saade GR, Hughes BL, Reddy UM, Chien EK, Tita ATN, Thorp JM, Metz TD, Sabharwal V, Simhan HN, Swamy GK, Heyborne KD, Sibai BM, Yee LM, El-Sayed YY, Casey BM, Parry S, Prasad M. Neonatal Inflammatory Profiles Associated With Perinatally Acquired Hepatitis C Viral Infection. Pediatr Infect Dis J. 2026 May 05. PMID: 42083082.

    Read at: PubMed

  • Published 3/20/2026

    Pierre-Joseph N, Sabharwal V, Borgaonkar R, Seide J, Mokhtar R, Do H, Fu D, Karkala E, Pelton S. Safety of dose 1 of the nine-valent human papillomavirus vaccine in children aged 4-8 years. J Pediatric Infect Dis Soc. 2026 Mar 20; 15(4). PMID: 41934252.

    Read at: PubMed

  • Published 2/4/2026

    Prasad M, Sandoval GJ, Saade GR, Hughes BL, Clifton RG, Reddy UM, Bartholomew A, Salazar A, Chien EK, Tita ATN, Thorp JM, Metz TD, Wapner RJ, Sabharwal V, Simhan HN, Swamy GK, Heyborne KD, Sibai BM, Grobman WA, El-Sayed YY, Casey BM, Parry S, Macones GA. Early Postnatal Polymerase Chain Reaction Testing in the Identification of Perinatal Transmission of Hepatitis C Virus. Clin Infect Dis. 2026 Feb 04; 81(6):1102-1105. PMID: 40653712.

    Read at: PubMed

  • Published 8/29/2025

    Martins MF, Teran Plasencia JM, Jacobson KR, Bouton TC, Traber KE, Canning M, Bourque DL, Sabharwal V, Michaud R, Sinha P, Acuña-Villaorduña CJ. Rifampin versus isoniazid completion rates for TB infection. Int J Tuberc Lung Dis. 2025 Aug 29; 29(9):425-427. PMID: 40883884.

    Read at: PubMed

  • Published 6/11/2025

    Campbell JI, Garing A, Lavache D, Bahad S, Hofman M, Haberer JE, Brooks MB, Sinha P, White LF, Sabharwal V, Tschampl CA, Horsburgh CR, Jenkins HE, Jacobson KR. Social Vulnerability Modifies the Effects of Geographic Proximity on Engagement in Latent Tuberculosis Infection Care in a United States Safety Net Healthcare Network. Open Forum Infect Dis. 2025 Jul; 12(7):ofaf347. PMID: 40606058.

    Read at: PubMed

View All 42 Publications:   View Full Profile in BUMC

Websites

Education

  • Government Medical College, Amritsar, MBBS

View all profiles